Seek Returns logo

CBT vs. DD: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at CBT and DD, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCBTDD
Company NameCabot CorporationDuPont de Nemours, Inc.
CountryUnited StatesUnited States
GICS SectorMaterialsMaterials
GICS IndustryChemicalsChemicals
Market Capitalization4.07 billion USD32.75 billion USD
ExchangeNYSENYSE
Listing DateNovember 5, 1980June 1, 1972
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of CBT and DD by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CBT vs. DD: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCBTDD
5-Day Price Return0.20%4.92%
13-Week Price Return1.40%9.48%
26-Week Price Return-9.00%2.98%
52-Week Price Return-31.38%-12.22%
Month-to-Date Return-6.76%0.41%
Year-to-Date Return-16.71%2.58%
10-Day Avg. Volume0.39M3.74M
3-Month Avg. Volume0.37M2.85M
3-Month Volatility33.60%24.22%
Beta0.931.10

Profitability

Return on Equity (TTM)

CBT

29.52%

Chemicals Industry

Max
29.52%
Q3
13.18%
Median
6.53%
Q1
1.35%
Min
-11.86%

In the upper quartile for the Chemicals industry, CBT’s Return on Equity of 29.52% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

DD

-0.83%

Chemicals Industry

Max
29.52%
Q3
13.18%
Median
6.53%
Q1
1.35%
Min
-11.86%

DD has a negative Return on Equity of -0.83%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

CBT vs. DD: A comparison of their Return on Equity (TTM) against the Chemicals industry benchmark.

Net Profit Margin (TTM)

CBT

11.14%

Chemicals Industry

Max
20.20%
Q3
9.15%
Median
3.94%
Q1
0.60%
Min
-10.43%

A Net Profit Margin of 11.14% places CBT in the upper quartile for the Chemicals industry, signifying strong profitability and more effective cost management than most of its peers.

DD

-1.54%

Chemicals Industry

Max
20.20%
Q3
9.15%
Median
3.94%
Q1
0.60%
Min
-10.43%

DD has a negative Net Profit Margin of -1.54%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

CBT vs. DD: A comparison of their Net Profit Margin (TTM) against the Chemicals industry benchmark.

Operating Profit Margin (TTM)

CBT

16.62%

Chemicals Industry

Max
27.33%
Q3
13.82%
Median
7.98%
Q1
3.60%
Min
-7.61%

An Operating Profit Margin of 16.62% places CBT in the upper quartile for the Chemicals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

DD

6.12%

Chemicals Industry

Max
27.33%
Q3
13.82%
Median
7.98%
Q1
3.60%
Min
-7.61%

DD’s Operating Profit Margin of 6.12% is around the midpoint for the Chemicals industry, indicating that its efficiency in managing core business operations is typical for the sector.

CBT vs. DD: A comparison of their Operating Profit Margin (TTM) against the Chemicals industry benchmark.

Profitability at a Glance

SymbolCBTDD
Return on Equity (TTM)29.52%-0.83%
Return on Assets (TTM)11.33%-0.53%
Net Profit Margin (TTM)11.14%-1.54%
Operating Profit Margin (TTM)16.62%6.12%
Gross Profit Margin (TTM)25.16%37.34%

Financial Strength

Current Ratio (MRQ)

CBT

2.13

Chemicals Industry

Max
3.72
Q3
2.38
Median
1.69
Q1
1.42
Min
0.75

CBT’s Current Ratio of 2.13 aligns with the median group of the Chemicals industry, indicating that its short-term liquidity is in line with its sector peers.

DD

1.41

Chemicals Industry

Max
3.72
Q3
2.38
Median
1.69
Q1
1.42
Min
0.75

DD’s Current Ratio of 1.41 falls into the lower quartile for the Chemicals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

CBT vs. DD: A comparison of their Current Ratio (MRQ) against the Chemicals industry benchmark.

Debt-to-Equity Ratio (MRQ)

CBT

0.79

Chemicals Industry

Max
1.53
Q3
1.00
Median
0.69
Q1
0.41
Min
0.00

CBT’s Debt-to-Equity Ratio of 0.79 is typical for the Chemicals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

DD

0.31

Chemicals Industry

Max
1.53
Q3
1.00
Median
0.69
Q1
0.41
Min
0.00

Falling into the lower quartile for the Chemicals industry, DD’s Debt-to-Equity Ratio of 0.31 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

CBT vs. DD: A comparison of their Debt-to-Equity Ratio (MRQ) against the Chemicals industry benchmark.

Interest Coverage Ratio (TTM)

CBT

11.80

Chemicals Industry

Max
56.43
Q3
26.33
Median
8.84
Q1
2.54
Min
-9.39

CBT’s Interest Coverage Ratio of 11.80 is positioned comfortably within the norm for the Chemicals industry, indicating a standard and healthy capacity to cover its interest payments.

DD

4.24

Chemicals Industry

Max
56.43
Q3
26.33
Median
8.84
Q1
2.54
Min
-9.39

DD’s Interest Coverage Ratio of 4.24 is positioned comfortably within the norm for the Chemicals industry, indicating a standard and healthy capacity to cover its interest payments.

CBT vs. DD: A comparison of their Interest Coverage Ratio (TTM) against the Chemicals industry benchmark.

Financial Strength at a Glance

SymbolCBTDD
Current Ratio (MRQ)2.131.41
Quick Ratio (MRQ)1.250.90
Debt-to-Equity Ratio (MRQ)0.790.31
Interest Coverage Ratio (TTM)11.804.24

Growth

Revenue Growth

CBT vs. DD: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CBT vs. DD: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CBT

2.36%

Chemicals Industry

Max
6.59%
Q3
3.67%
Median
2.44%
Q1
1.36%
Min
0.00%

CBT’s Dividend Yield of 2.36% is consistent with its peers in the Chemicals industry, providing a dividend return that is standard for its sector.

DD

2.02%

Chemicals Industry

Max
6.59%
Q3
3.67%
Median
2.44%
Q1
1.36%
Min
0.00%

DD’s Dividend Yield of 2.02% is consistent with its peers in the Chemicals industry, providing a dividend return that is standard for its sector.

CBT vs. DD: A comparison of their Dividend Yield (TTM) against the Chemicals industry benchmark.

Dividend Payout Ratio (TTM)

CBT

22.35%

Chemicals Industry

Max
192.00%
Q3
108.95%
Median
57.38%
Q1
27.28%
Min
0.00%

CBT’s Dividend Payout Ratio of 22.35% is in the lower quartile for the Chemicals industry. This suggests a conservative dividend policy, with a strategic focus on reinvesting profits for future growth.

DD

64.33%

Chemicals Industry

Max
192.00%
Q3
108.95%
Median
57.38%
Q1
27.28%
Min
0.00%

DD’s Dividend Payout Ratio of 64.33% is within the typical range for the Chemicals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CBT vs. DD: A comparison of their Dividend Payout Ratio (TTM) against the Chemicals industry benchmark.

Dividend at a Glance

SymbolCBTDD
Dividend Yield (TTM)2.36%2.02%
Dividend Payout Ratio (TTM)22.35%64.33%

Valuation

Price-to-Earnings Ratio (TTM)

CBT

9.48

Chemicals Industry

Max
49.43
Q3
32.03
Median
21.32
Q1
14.93
Min
8.66

In the lower quartile for the Chemicals industry, CBT’s P/E Ratio of 9.48 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

DD

--

Chemicals Industry

Max
49.43
Q3
32.03
Median
21.32
Q1
14.93
Min
8.66

P/E Ratio data for DD is currently unavailable.

CBT vs. DD: A comparison of their Price-to-Earnings Ratio (TTM) against the Chemicals industry benchmark.

Price-to-Sales Ratio (TTM)

CBT

1.06

Chemicals Industry

Max
3.90
Q3
2.23
Median
1.00
Q1
0.55
Min
0.15

CBT’s P/S Ratio of 1.06 aligns with the market consensus for the Chemicals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

DD

2.60

Chemicals Industry

Max
3.90
Q3
2.23
Median
1.00
Q1
0.55
Min
0.15

DD’s P/S Ratio of 2.60 is in the upper echelon for the Chemicals industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

CBT vs. DD: A comparison of their Price-to-Sales Ratio (TTM) against the Chemicals industry benchmark.

Price-to-Book Ratio (MRQ)

CBT

2.61

Chemicals Industry

Max
5.01
Q3
2.59
Median
1.50
Q1
0.95
Min
0.30

CBT’s P/B Ratio of 2.61 is in the upper tier for the Chemicals industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

DD

1.24

Chemicals Industry

Max
5.01
Q3
2.59
Median
1.50
Q1
0.95
Min
0.30

DD’s P/B Ratio of 1.24 is within the conventional range for the Chemicals industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

CBT vs. DD: A comparison of their Price-to-Book Ratio (MRQ) against the Chemicals industry benchmark.

Valuation at a Glance

SymbolCBTDD
Price-to-Earnings Ratio (TTM)9.48--
Price-to-Sales Ratio (TTM)1.062.60
Price-to-Book Ratio (MRQ)2.611.24
Price-to-Free Cash Flow Ratio (TTM)11.5724.81